📣 VC round data is live. Check it out!

Teijin Valuation Multiples

Discover revenue and EBITDA valuation multiples for Teijin and similar public comparables like Robertet, Castrol India, Alzchem Group, Advanced Petrochemical and more.

Teijin Overview

About Teijin

Teijin Ltd is a Japanese industrial conglomerate engaged in healthcare, materials, textiles, and other businesses. The company organizes itself into four primary segments. The Healthcare segment manufactures and sells pharmaceuticals, medical devices, and home medical services. The Material segment covers aramid fibers, polycarbonate resins, carbon fibers, and composite molding materials. The Textiles/Products segment produces polyester fibers and textile products. The Others segment includes businesses outside the reporting segments, such as battery components, membranes, regenerative medicine, and implantable medical devices.


Founded

1918

HQ

Japan

Employees

22.0K

Financials (LTM)

Revenue: $6B
EBITDA: $329M

EV

$4B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Teijin Financials

Teijin reported last 12-month revenue of $6B and EBITDA of $329M.

In the same LTM period, Teijin generated $1B in gross profit, $329M in EBITDA, and had net loss of ($133M).


Teijin P&L

In the most recent fiscal year, Teijin reported revenue of $7B and EBITDA of $28M.

Teijin is profitable as of last fiscal year, with gross margin of 18%, EBITDA margin of 0%, and net margin of 3%.

See analyst estimates for Teijin
LTMLast FY202320242025202620272028
Revenue$6B$7B$7B$6B$6B
Gross Profit$1B$1B$2B$1B$1B
Gross Margin22%18%26%21%21%
EBITDA$329M$28M$694M$209M$228M
EBITDA Margin6%0%11%3%4%
EBIT Margin2%3%1%(5%)(0%)
Net Profit($133M)$191M$23M$153M($78M)
Net Margin(2%)3%0%2%(1%)
Net Debt$2B

Financial data powered by Morningstar, Inc.

Teijin Stock Performance

Teijin has current market cap of $2B, and enterprise value of $4B.


Teijin's stock price is $10.00.

Teijin has an EPS (earnings per share) of $0.99.

See more trading valuation data for Teijin
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$4B$2B0.1%$0.99

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Teijin Valuation Multiples

Teijin trades at 0.6x EV/Revenue multiple, and 10.8x EV/EBITDA.

See NTM and 2027E valuation multiples for Teijin

Teijin Financial Valuation Multiples

As of May 10, 2026, Teijin has market cap of $2B and EV of $4B.

Teijin has a P/E ratio of (14.5x).

LTMLast FY202320242025202620272028
EV/Revenue0.6x0.5x0.5x0.5x0.6x
EV/EBITDA10.8x127.4x5.1x17.0x15.6x
EV/EBIT26.3x19.1x41.6x(11.0x)(189.5x)
EV/Gross Profit2.9x2.9x2.1x2.6x3.0x
P/E(14.5x)10.1x85.7x12.6x(24.6x)
EV/FCF20.3x4.3x210.4x75.0x24.4x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Teijin Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Teijin Margins & Growth Rates

Teijin decreased revenue by 19% but EBITDA grew by 957% in the last fiscal year.

In the most recent fiscal year, Teijin reported gross margin of 18%, EBITDA margin of 0%, and net margin of 3%.

See estimated margins and future growth rates for Teijin

Teijin Margins

Last FY202420252026202720282029
Gross Margin18%21%21%27%
EBITDA Margin0%3%4%9%
EBIT Margin3%(5%)(0%)3%
Net Margin3%2%(1%)1%
FCF Margin12%1%3%3%

Teijin Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(19%)(2%)(11%)(2%)
Gross Profit Growth(2%)(21%)(11%)25%
EBITDA Growth957%(70%)9%131%
EBIT Growth(31%)(478%)(94%)(1037%)
Net Profit Growth(186%)578%(151%)(165%)
FCF Growth(79%)180%208%13%

Data powered by FactSet, Inc. and Morningstar, Inc.

Teijin Operational KPIs

Teijin's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.

Teijin's Rule of 40 is 7% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Teijin's Rule of X is 3% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Teijin
LTMLast FY202320242025202620272028
Rule of 409%7%
Bessemer Rule of X13%3%
Revenue per Employee$0.3M
Opex per Employee$0.1M
G&A Expenses to Revenue25%25%27%30%
Opex to Revenue25%25%26%29%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Teijin Competitors

Teijin competitors include Robertet, Castrol India, Alzchem Group, Advanced Petrochemical, Zhenghai Magnetic Material, Abu Qir Fertilizers, Innospec, Chengzhi, Solvac and Saudi Chemical.

Most Teijin public comparables operate across Chemicals, Advanced Materials and DeepTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Robertet2.0x2.0x9.6x9.9x
Castrol India3.0x2.8x12.4x12.4x
Alzchem Group2.8x2.7x13.2x13.1x
Advanced Petrochemical4.7x4.0x19.5x16.7x
Zhenghai Magnetic Material1.4x1.3x18.8x
Abu Qir Fertilizers2.8x1.7x6.2x3.4x
Innospec1.0x1.0x8.7x8.9x
Chengzhi1.5x18.1x

This data is available for Pro users. Sign up to see all Teijin competitors and their valuation data.

Start Free Trial

Teijin Investment Activity

Teijin has invested in 5 companies to date.

Latest investment by Teijin was on March 30th 2022. Teijin invested in Linkage in their $5M Series A round (EV/Revenue multiple of ).

See VC round multiples

Latest Investments by Teijin

Linkage
3Sunny
Floadia
MiRTeL
Description
Linkage is a Tokyo-based online health support platform offering specific health guidance services in Japan. The company provides virtual consultations, lifestyle coaching, and preventive care programs compliant with national health insurance guidelines. Linkage partners with corporations for employee wellness and metabolic syndrome management.
3Sunny is a Tokyo-headquartered health technology company founded in 2016 that deploys digital tools to streamline medical workflows and patient care in Japan. It offers platforms for remote consultations, inventory management in clinics, and compliance tracking for healthcare providers, addressing gaps in rural and urban medical access. The firm partners with hospitals and pharmacies to integrate AI-driven scheduling and data analytics for operational efficiency.
Floadia Corporation is a Tokyo-based semiconductor IP provider specializing in embedded non-volatile memory solutions. Engineers from Renesas developed Split-Gate Flash technology, including Source Side Injection architecture used in modern NOR Flash. Floadia's IP cores target MCUs and SoCs for automotive and IoT applications, offering densities up to 64 Mbit with low power consumption. Partnerships with foundries like TSMC enable 28nm and 40nm processes. Founded in 2009, Floadia licenses technology to Japanese electronics firms.
MiRTeL is a Hiroshima University spin-off specializing in medical telecommunications technology. Established in 2004, it develops remote diagnostic systems and wearable devices for telemedicine, serving hospitals across Japan with ECG monitoring and vital signs transmission over cellular networks.
HQ CountryJapanJapanJapanJapan
HQ City
Tokyo
Kodaira
Hiroshima
Deal Date30 Mar 20224 Mar 202126 Oct 202024 Apr 2020
RoundSeries ASeedSeries CSeed
Raised$5M$3M$10M$4M
InvestorsKaga Electronics; Mynavi; Takeuchi Makoto; TeijinANOBAKA; ANRI; Fujimoto Shuuhei; Medius Holdings Co; Persol Innovation Fund; Reimu Sugita; Saaya Nakayama; TeijinIDATEN Ventures; Marubeni; Miyako Capital; NEC Capital Solutions; Teijin; TEL Venture Capital; Venture Labo InvestmentHiroshima Innovation Network; Hiroshima Venture Capital; Teijin
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Teijin investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Teijin

When was Teijin founded?Teijin was founded in 1918.
Where is Teijin headquartered?Teijin is headquartered in Japan.
How many employees does Teijin have?As of today, Teijin has over 22K employees.
Is Teijin publicly listed?Yes, Teijin is a public company listed on Tokyo Stock Exchange.
What is the stock symbol of Teijin?Teijin trades under 3401 ticker.
When did Teijin go public?Teijin went public in 1949.
Who are competitors of Teijin?Teijin main competitors include Robertet, Castrol India, Alzchem Group, Advanced Petrochemical, Zhenghai Magnetic Material, Abu Qir Fertilizers, Innospec, Chengzhi, Solvac, Saudi Chemical.
What is the current market cap of Teijin?Teijin's current market cap is $2B.
What is the current revenue of Teijin?Teijin's last 12 months revenue is $6B.
What is the current revenue growth of Teijin?Teijin revenue growth (NTM/LTM) is 3%.
What is the current EV/Revenue multiple of Teijin?Current revenue multiple of Teijin is 0.6x.
Is Teijin profitable?Yes, Teijin is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Teijin?Teijin's last 12 months EBITDA is $329M.
What is Teijin's EBITDA margin?Teijin's last 12 months EBITDA margin is 6%.
What is the current EV/EBITDA multiple of Teijin?Current EBITDA multiple of Teijin is 10.8x.
What is the current FCF of Teijin?Teijin's last 12 months FCF is $175M.
What is Teijin's FCF margin?Teijin's last 12 months FCF margin is 3%.
What is the current EV/FCF multiple of Teijin?Current FCF multiple of Teijin is 20.3x.
How many companies Teijin has acquired to date?Teijin hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Teijin has invested to date?As of May 2026, Teijin has invested in 5 companies.
What was the last Teijin investment?On 30th March 2022 Teijin invested in Linkage, participating in a $5M Series A round, alongside Kaga Electronics, Mynavi, and Takeuchi Makoto.
In what companies Teijin invested in?Teijin invested in APB, Floadia, Linkage, MiRTeL, and 3Sunny.

See public comps similar to Teijin

Lists including Teijin

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial